DTMT Network

The Indian Ministry of Ayush has signed an MoU with the Pharmacopoeia Commission for Indian Medicine and Homoeopathy (PCIM&H) and American Herbal Pharmacopoeia to boost the quality of Ayurvedic drugs in the global community.

The Ministry expects that the agreement will develop the confidence of the global community about the safety of Ayush drugs.

The ministry has stated that this collaboration of efforts will go a long way in enhancing the export potential of the Ayurveda, Siddha, Unani, and Homeopathy drugs.

“Under this MOU, there will be the constitution of a Joint Committee to develop the action plan along with timelines for the development of Monographs and other activities for cooperation in the field of Traditional Medicine,” the ministry said.

“One of the major outcomes of this partnership will be that both PCIM&H and AHP, USA would be working to identify various challenges faced by the herbal market of Ayurveda products/drugs in the USA,” the ministry stated in the statement.

The ministry said that this will lead to the adoption of Ayurveda standards developed out of this cooperation by the manufacturers of herbal drugs in the USA.

It further added that this can be termed as a major move and will eventually foster the adoption of Ayurveda standards developed out of this cooperation for the market authorisation of Ayush products/drugs in the USA.